DEMES-CARDIOVASCULAR Surgery: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DEMES-CARDIOVASCULAR Surgery
Largest movements
- Cash +€99,532
up €99,532 (+372%), from €26,786 to €126,318
mainly Net result for the year (+€123,363) and Tax, wage and social debts (+€16,623)
- Receivables within one year +€35,657
up €35,657 (+107%), from €33,239 to €68,897
- Tangible fixed assets +€5,536
up €5,536 (+1,446%), from €383 to €5,919
- Profit (loss) carried forward +€123,363
up €123,363 (+287%), from €42,939 to €166,302
- Tax, wage and social debts +€16,623
up €16,623 (+118%), from €14,042 to €30,665
- Gross operating margin +€105,177
up €105,177 (+190%), from €55,414 to €160,591
- Taxes +€24,872
up €24,872 (+229%), from €10,875 to €35,747
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €60,875 | €201,549 | +€140,673 | +231% |
| Fixed assets | 21/28 | €383 | €5,919 | +€5,536 | +1,446% |
| Tangible fixed assets | 22/27 | €383 | €5,919 | +€5,536 | +1,446% |
| Furniture and vehicles | 24 | €383 | €5,919 | +€5,536 | +1,446% |
| Current assets | 29/58 | €60,492 | €195,630 | +€135,137 | +223% |
| Amounts receivable within one year | 40/41 | €33,239 | €68,897 | +€35,657 | +107% |
| Other amounts receivable | 41 | €33,239 | €68,897 | +€35,657 | +107% |
| Cash at bank and in hand | 54/58 | €26,786 | €126,318 | +€99,532 | +372% |
| Deferred charges and accrued income | 490/1 | €467 | €415 | -€52 | -11.1% |
| Total equity and liabilities | 10/49 | €60,875 | €201,549 | +€140,673 | +231% |
| Equity | 10/15 | €44,939 | €168,302 | +€123,363 | +275% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €42,939 | €166,302 | +€123,363 | +287% |
| Amounts payable | 17/49 | €15,937 | €33,247 | +€17,310 | +109% |
| Amounts payable within one year | 42/48 | €15,937 | €33,247 | +€17,310 | +109% |
| Trade debts | 44 | €1,754 | €2,045 | +€292 | +16.6% |
| Suppliers | 440/4 | €1,754 | €2,045 | +€292 | +16.6% |
| Taxes, remuneration and social security | 45 | €14,042 | €30,665 | +€16,623 | +118% |
| Taxes | 450/3 | €14,042 | €30,665 | +€16,623 | +118% |
| Other amounts payable | 47/48 | €142 | €537 | +€395 | +279% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,601 | €1,463 | -€138 | -8.6% |
| Other operating charges | 640/8 | - | €224 | +€224 | |
| Gross operating margin | 9900 | €55,414 | €160,591 | +€105,177 | +190% |
| Operating profit (loss) | 9901 | €53,814 | €158,905 | +€105,091 | +195% |
| Financial income | 75/76B | - | €273 | +€273 | |
| Recurring financial income | 75 | - | €273 | +€273 | |
| Financial charges | 65/66B | -€0 | €68 | +€68 | |
| Recurring financial charges | 65 | -€0 | €68 | +€68 | |
| Profit (loss) for the period before taxes | 9903 | €53,814 | €159,110 | +€105,296 | +196% |
| Income taxes | 67/77 | €10,875 | €35,747 | +€24,872 | +229% |
| Profit (loss) for the period | 9904 | €42,939 | €123,363 | +€80,424 | +187% |
| Profit (loss) for the period to be appropriated | 9905 | €42,939 | €123,363 | +€80,424 | +187% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.